Prevalence and significance of antiphospholipid antibodies in selected at-risk obstetrics cases: A comparative prospective study

References

• Aoki K, Hayashi Y, Hirao Y, Yagami Y. Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss. American Journal of Reproductive Immunology 1993; 29: 82–87
   PubMed Web of Science ®Google Scholar
• Balasch J, Creus M, Fábregues F, Reverter J C, Carmona F, Tàssies D, et al. Antiphospholipid antibodies and human reproductive failure. Human Reproduction 1996; 11: 2310–2315
   PubMed Web of Science ®Google Scholar
• Barbui T, Cortelazzo S, Galli M, Parazzini F. Antiphospholipid antibodies in early repeated abortions: A case controlled study. Fertility and Sterility 1988; 50: 589–592
   PubMed Web of Science ®Google Scholar
• Birdsall M, Pattison N, Chamley L. Antiphospholipid antibodies in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2008; 32: 328–330
   Google Scholar
• Branch D W. Antiphospholipid antibodies and reproductive outcome: the current state of affairs. Journal of Reproductive Immunology 1998; 38: 75–87
   PubMed Web of Science ®Google Scholar
• Branch D W, Silver R M, Blackwell J L, Reading J C, Scott J R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstetrics and Gynecology 1992; 80: 614–620
   PubMed Web of Science ®Google Scholar
• Branch D W, Silver R M, Pierangelli S S, Reading J C, Scott J R. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstetrics and Gynecology 1997; 89: 549–555
   PubMed Web of Science ®Google Scholar
• Carreras L O, Defreyn G, Machin S J, Vermylen J, Deman R, Spitz B, et al. Arterial thrombosis, intrauterine death and lupus anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244–246
   PubMed Web of Science ®Google Scholar
• el-Roeiy A, Myers S A, Gleicher N. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstetrics and Gynecology 1990; 75: 390–396
   PubMed Web of Science ®Google Scholar
• Galli M, Barbui T. Antiphospholipid antibodies and pregnancy. Best Practice and Research Clinical Haematology 2003; 16: 211–225
   PubMed Web of Science ®Google Scholar
• Garlund B. The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. Acta Medica Scandinavica 1984; 215: 293–298
   PubMedGoogle Scholar
• Granger K A. Review: Obstetric outcome in antiphospholipid syndrome. Lupus 1997; 6: 509–513
   PubMed Web of Science ®Google Scholar
• Harris E N, Spinnato J A. Should anticardiolipin tests be performed in otherwise healthy pregnant women. American Journal of Obstetrics and Gynecology 1991; 165: 1272–1277
   PubMed Web of Science ®Google Scholar
• Kutteh W H, Rote N S, Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. American Journal of Reproductive Immunology 1999; 41: 133–152
   PubMed Web of Science ®Google Scholar
• Kwak J YH, Gilman Sachs A, Beaman K D, Beer A E. Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology. Journal of Reproductive Immunology 1992; 22: 15–31
   PubMed Web of Science ®Google Scholar
• Lockshin M D, Druzin M L, Qamar T. Antibody to cardiolipin, lupus anticoagulant and fetal death. Journal of Rheumatology 1987; 14: 259–262
   PubMed Web of Science ®Google Scholar
• Lockwood C J, Romero R, Geinberg R F, Clyne L P, Coster B, Hobin J C. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. American Journal of Obstetrics and Gynecology 1989; 161: 369–373
   PubMed Web of Science ®Google Scholar
• Love P E, Santoro S A. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in Non-SLE disorders. Annals of Internal Medicine 1990; 112: 682–698
   PubMed Web of Science ®Google Scholar
• Lynch A, Marlar R, Murphy J, Davila G, Santos M, Rutledge J, et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome: A prospective study. Annals of Internal Medicine 1994; 120: 470–475
   PubMed Web of Science ®Google Scholar
• Milliez J, Lelong F, Bayani N, Jannet D, el Medjadji M, Latrous H, et al. The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. American Journal of Obstetrics and Gynecology 1991; 7: 51–57
   Google Scholar
• Nilsson I M, Astedt B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant (antithromboplastin). Acta Medica Scandinavica 1975; 197: 153–159
   PubMedGoogle Scholar
• Out H J, Bruinse H W, Christiaens G C, van Vliet M, Meilof J F, de Groot P G, et al. Prevalence of antiphospholipid antibodies in patients with fetal loss. Annals of the Rheumatic Diseases 1991; 50: 553–557
   PubMed Web of Science ®Google Scholar
• Rai R, Cohen H, Dave M, Regan L. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. British Medical Journal 1997; 314: 253–257
   PubMed Web of Science ®Google Scholar
• Ruffatti A, Orsini A, Di Lenardo L, Nardelli G B, Patrassi G M, Truscia D, et al. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss. Clinical and Experimental Rheumatology 1997; 15: 499–505
   PubMed Web of Science ®Google Scholar
• Silver R M, Porter T F, van Leeuween I, Jeng G, Scott J R, Branch D W. Anticardiolipin antibodies: clinical consequences of ‘low titres’. Obstetrics and Gynecology 1996; 87: 494–500
   PubMed Web of Science ®Google Scholar
• Taylor M, Cauchi M N, Buchanan R R. The lupus anticoagulant, anticardiolipin antibodies and recurrent miscarriage. American Journal of Reproductive Immunology 1990; 23: 33–36
   PubMed Web of Science ®Google Scholar
• Triplett D A, Harris E N. Antiphospholipid antibodies and reproduction. American Journal of Reproductive Immunology 1989; 21: 3–4
   Google Scholar
• Triplett D A, Brandt J T, Maas R L. The laboratory heterogeneity of lupus anticoagulants. Archives of Pathology and Laboratory Medicine 1985; 109: 946–951
   PubMed Web of Science ®Google Scholar
• Weidmann C E, Wallace D J, Peter J B, Knight P J, Bear M B, Klinenberg J R. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. Journal of Rheumatology 1988; 15: 74–79
   PubMed Web of Science ®Google Scholar
• Wilson W A, Gharavi A E, Koike T, Lockshin M D, Branch D W, Piette J C, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis and Rheumatism 1999; 42: 1309–1311
   PubMed Web of Science ®Google Scholar